SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-19-000121
Filing Date
2019-03-28
Accepted
2019-03-28 16:32:07
Documents
82
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K body10k.htm 10-K 1033293
2 SUBSIDIARIES exh21-1.htm EX-21.1 1091
3 CONSENT exh23-1.htm EX-23.1 1834
4 302 CERTIFICATE exh31-1.htm EX-31.1 7466
5 906 CERTIFICATE exh32-1.htm EX-32.1 2548
  Complete submission text file 0001136261-19-000121.txt   6966141

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT seel-20181231.xml EX-101.INS 731085
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT seel-20181231.xsd EX-101.SCH 71240
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT seel-20181231_cal.xml EX-101.CAL 79262
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT seel-20181231_def.xml EX-101.DEF 440087
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT seel-20181231_lab.xml EX-101.LAB 527295
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT seel-20181231_pre.xml EX-101.PRE 562136
Mailing Address 300 PARK AVENUE NEW YORK NY 10017
Business Address 300 PARK AVENUE NEW YORK NY 10017 (646) 998-6475
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-22245 | Film No.: 19712418
SIC: 2834 Pharmaceutical Preparations